| EPB065 | Cluster-randomized trial of routine syphilis screening among men attending HIV outpatient clinics in Ontario, Canada | E-poster | STIs (including HPV) |
| EPC155 | Closing the gaps in the continuum of depression care among persons with HIV: modeling the impact on viral load suppression in the United States | E-poster | Modelling the impact of service models on the HIV epidemic |
| EPD361 | Closing HIV case finding gaps amidst COVID, natural disasters, cross border migration, and socioeconomic challenges in Burundi | E-poster | Humanitarian crises and HIV |
| EPB041 | Clinical and virologic outcomes of TB/HIV co-infected patients treated with dolutegravir-based HIV antiretroviral regimens: programmatic experience from Nigeria | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| PEMOA27 | Clinical and immunometabolic patterns determining efficacy of DC-treatment reinvigorating HIV-1-specific CD8+ T cells in PLWH | Poster exhibition | Immunotherapy (including broadly neutralizing antibodies) |
| EPC081 | Clinical and demographic characteristics of tuberculosis patients in health care facilities in Botswana: a retrospective analysis | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
| EPD217 | Clinic and community case finding to prevent and identify new HIV infections among children and adolescents at risk and improve treatment outcomes for those living with HIV in rural Malawi | E-poster | Community-based approaches (including empowerment, outreach and service delivery) |
| EPE305 | Client satisfaction with antiretroviral treatment services in public health facilities south Ethiopia: institution based cross-sectional study | E-poster | Systems serving underserved populations |
| EPE424 | Circumventing the impact of COVID-19 pandemic on access to HIV-1 RNA assay in Nigeria | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PESAB05 | Circulating mir21 and mir125b in women living with human immunodeficiency virus: utility of biomarkers for monitoring cervical carcinogenesis | Poster exhibition | Diagnostics of co-infections and co-morbidities |